<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37189455</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>21</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>Vitamin D and Autoimmune Rheumatic Diseases.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">709</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom13040709</ELocationID><Abstract><AbstractText>Vitamin D is a steroid hormone with potent immune-modulating properties. It has been shown to stimulate innate immunity and induce immune tolerance. Extensive research efforts have shown that vitamin D deficiency may be related to the development of autoimmune diseases. Vitamin D deficiency has been observed in patients with rheumatoid arthritis (RA) and has been shown to be inversely related to disease activity. Moreover, vitamin D deficiency may be implicated in the pathogenesis of the disease. Vitamin D deficiency has also been observed in patients with systemic lupus erythematosus (SLE). It has been found to be inversely related to disease activity and renal involvement. In addition, vitamin D receptor polymorphisms have been studied in SLE. Vitamin D levels have been studied in patients with Sjogren's syndrome, and vitamin D deficiency may be related to neuropathy and the development of lymphoma in the context of Sjogren's syndrome. Vitamin D deficiency has been observed in ankylosing spondylitis, psoriatic arthritis (PsA), and idiopathic inflammatory myopathies. Vitamin D deficiency has also been observed in systemic sclerosis. Vitamin D deficiency may be implicated in the pathogenesis of autoimmunity, and it may be administered to prevent autoimmune disease and reduce pain in the context of autoimmune rheumatic disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Athanassiou</LastName><ForeName>Lambros</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Asclepeion Hospital, Voula, GR16673 Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology, Medical School, University of Athens, GR11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kostoglou-Athanassiou</LastName><ForeName>Ifigenia</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0002-2029-8372</Identifier><AffiliationInfo><Affiliation>Department of Endocrinology, Asclepeion Hospital, Voula, GR16673 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koutsilieris</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Physiology, Medical School, University of Athens, GR11527 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoenfeld</LastName><ForeName>Yehuda</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel Aviv University, Tel Aviv 69978, Israel.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014815">Vitamins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015535" MajorTopicYN="N">Arthritis, Psoriatic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012859" MajorTopicYN="N">Sjogren's Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="Y">Vitamin D</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014808" MajorTopicYN="Y">Vitamin D Deficiency</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014815" MajorTopicYN="N">Vitamins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Sjogren&#x2019;s syndrome</Keyword><Keyword MajorTopicYN="N">ankylosing spondylitis</Keyword><Keyword MajorTopicYN="N">rheumatoid arthritis</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword><Keyword MajorTopicYN="N">systemic sclerosis</Keyword><Keyword MajorTopicYN="N">vitamin D</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>16</Day><Hour>1</Hour><Minute>9</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37189455</ArticleId><ArticleId IdType="pmc">PMC10135889</ArticleId><ArticleId IdType="doi">10.3390/biom13040709</ArticleId><ArticleId IdType="pii">biom13040709</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sassi F., Tamone C., D&#x2019;Amelio P. Vitamin D: Nutrient, Hormone, and Immunomodulator. Nutrients. 2018;10:1656. doi: 10.3390/nu10111656.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10111656</ArticleId><ArticleId IdType="pmc">PMC6266123</ArticleId><ArticleId IdType="pubmed">30400332</ArticleId></ArticleIdList></Reference><Reference><Citation>Christakos S., Li S., De La Cruz J., Bikle D.D. New developments in our understanding of vitamin metabolism, action and treatment. Metabolism. 2019;98:112&#x2013;120. doi: 10.1016/j.metabol.2019.06.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2019.06.010</ArticleId><ArticleId IdType="pmc">PMC6814307</ArticleId><ArticleId IdType="pubmed">31226354</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams C. On the use and administration of cod-liver oil in pulmonary consumption. Lond. J. Med. 1849;1:50. doi: 10.1097/00000441-184910000-00039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00000441-184910000-00039</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsen N. Nobel prize presentation speech by professor the count KAH Morner. Rector R. Caroline Inst. Dec. 1903;10:1903.</Citation></Reference><Reference><Citation>Moller K.I., Kongshoj B., Philipsen P.A., Thomsen V.O., Wulf H.C. How Finsen&#x2019;s light cured lupus vulgaris. Photodermatol. Photoimmunol. Photomed. 2005;21:118&#x2013;124. doi: 10.1111/j.1600-0781.2005.00159.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0781.2005.00159.x</ArticleId><ArticleId IdType="pubmed">15888127</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapira Y., Agmon-Levin N., Shoenfeld Y. Mycobacterium tuberculosis, autoimmunity, and vitamin D. Clin. Rev. Allergy Immunol. 2010;38:169&#x2013;177. doi: 10.1007/s12016-009-8150-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-009-8150-1</ArticleId><ArticleId IdType="pubmed">19543859</ArticleId></ArticleIdList></Reference><Reference><Citation>Rook G.A., Steele J., Fraher L., Barker S., Karmali R., O&#x2019;Riordan J., Stanford J. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology. 1986;57:159&#x2013;163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1453883</ArticleId><ArticleId IdType="pubmed">3002968</ArticleId></ArticleIdList></Reference><Reference><Citation>Soeharto D.A., Rifai D.A., Marsudidjadja S., Roekman A.E., Assegaf C.K., Louisa M. Vitamin D as an Adjunctive Treatment to Standard Drugs in Pulmonary Tuberculosis Patients: An Evidence-Based Case Report. Adv. Prev. Med. 2019;2019:5181847. doi: 10.1155/2019/5181847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/5181847</ArticleId><ArticleId IdType="pmc">PMC6610748</ArticleId><ArticleId IdType="pubmed">31321102</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira A.L.G., Chaves A.T., Menezes C.A.S., Guimaraes N.S., Bueno L.L., Fujiwara R.T., Rocha M. Vitamin D receptor expression and hepcidin levels in the protection or severity of leprosy: A systematic review. Microbes Infect. 2017;19:311&#x2013;322. doi: 10.1016/j.micinf.2017.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2017.03.001</ArticleId><ArticleId IdType="pubmed">28323068</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh I., Lavania M., Pathak V.K., Ahuja M., Turankar R.P., Singh V., Sengupta U. VDR polymorphism, gene expression and vitamin D levels in leprosy patients from North Indian population. PLoS Negl. Trop. Dis. 2018;12:e0006823. doi: 10.1371/journal.pntd.0006823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0006823</ArticleId><ArticleId IdType="pmc">PMC6286024</ArticleId><ArticleId IdType="pubmed">30481178</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu M., Wang T., Wang C., Ji Y. The association between vitamin D and COPD risk, severity, and exacerbation: An updated systematic review and meta-analysis. Int. J. Chron. Obs. Pulmon. Dis. 2016;11:2597&#x2013;2607. doi: 10.2147/COPD.S101382.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S101382</ArticleId><ArticleId IdType="pmc">PMC5079694</ArticleId><ArticleId IdType="pubmed">27799758</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgieva V., Kamolvit W., Herthelius M., Luthje P., Brauner A., Chromek M. Association between vitamin D, antimicrobial peptides and urinary tract infection in infants and young children. Acta Paediatr. 2019;108:551&#x2013;556. doi: 10.1111/apa.14499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/apa.14499</ArticleId><ArticleId IdType="pubmed">30003595</ArticleId></ArticleIdList></Reference><Reference><Citation>Szymczak I., Pawliczak R. The Active Metabolite of Vitamin D3 as a Potential Immunomodulator. Scand. J. Immunol. 2016;83:83&#x2013;91. doi: 10.1111/sji.12403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12403</ArticleId><ArticleId IdType="pubmed">26678915</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P.T., Stenger S., Li H., Wenzel L., Tan B.H., Krutzik S.R., Ochoa M.T., Schauber J., Wu K., Meinken C., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770&#x2013;1773. doi: 10.1126/science.1123933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1123933</ArticleId><ArticleId IdType="pubmed">16497887</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei R., Christakos S. Mechanisms Underlying the Regulation of Innate and Adaptive Immunity by Vitamin D. Nutrients. 2015;7:8251&#x2013;8260. doi: 10.3390/nu7105392.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu7105392</ArticleId><ArticleId IdType="pmc">PMC4632412</ArticleId><ArticleId IdType="pubmed">26404359</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutolo M. Vitamin D or hormone D deficiency in autoimmune rheumatic diseases, including undifferentiated connective tissue disease. Arthritis Res. Ther. 2008;10:123. doi: 10.1186/ar2552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar2552</ArticleId><ArticleId IdType="pmc">PMC2656237</ArticleId><ArticleId IdType="pubmed">19090978</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutolo M., Plebani M., Shoenfeld Y., Adorini L., Tincani A. Vitamin D endocrine system and the immune response in rheumatic diseases. Vitam. Horm. 2011;86:327&#x2013;351. doi: 10.1016/b978-0-12-386960-9.00014-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/b978-0-12-386960-9.00014-9</ArticleId><ArticleId IdType="pubmed">21419278</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutolo M., Otsa K., Paolino S., Yprus M., Veldi T., Seriolo B. Vitamin D involvement in rheumatoid arthritis and systemic lupus erythaematosus. Ann. Rheum. Dis. 2009;68:446&#x2013;447. doi: 10.1136/ard.2008.093476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2008.093476</ArticleId><ArticleId IdType="pubmed">19213751</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick M.F. The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention. Rev. Endocr. Metab. Disord. 2017;18:153&#x2013;165. doi: 10.1007/s11154-017-9424-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-017-9424-1</ArticleId><ArticleId IdType="pubmed">28516265</ArticleId></ArticleIdList></Reference><Reference><Citation>Charoenngam N., Holick M.F. Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients. 2020;12:97. doi: 10.3390/nu12072097.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12072097</ArticleId><ArticleId IdType="pmc">PMC7400911</ArticleId><ArticleId IdType="pubmed">32679784</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahn J., Cook N.R., Alexander E.K., Friedman S., Walter J., Bubes V., Kotler G., Lee I.M., Manson J.E., Costenbader K.H. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 2022;376:e066452. doi: 10.1136/bmj-2021-066452.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-066452</ArticleId><ArticleId IdType="pmc">PMC8791065</ArticleId><ArticleId IdType="pubmed">35082139</ArticleId></ArticleIdList></Reference><Reference><Citation>Ao T., Kikuta J., Ishii M. The Effects of Vitamin D on Immune System and Inflammatory Diseases. Biomolecules. 2021;11:1624. doi: 10.3390/biom11111624.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11111624</ArticleId><ArticleId IdType="pmc">PMC8615708</ArticleId><ArticleId IdType="pubmed">34827621</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrison S.R., Li D., Jeffery L.E., Raza K., Hewison M. Vitamin D, Autoimmune Disease and Rheumatoid Arthritis. Calcif. Tissue Int. 2020;106:58&#x2013;75. doi: 10.1007/s00223-019-00577-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-019-00577-2</ArticleId><ArticleId IdType="pmc">PMC6960236</ArticleId><ArticleId IdType="pubmed">31286174</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y.H., Bae S.C. Vitamin D level in rheumatoid arthritis and its correlation with the disease activity: A meta-analysis. Clin. Exp. Rheumatol. 2016;34:827&#x2013;833.</Citation><ArticleIdList><ArticleId IdType="pubmed">27049238</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee W.L., Lee F.K., Wang P.H. Vitamin D and systemic lupus erythematous. J. Chin. Med. Assoc. 2022;85:811&#x2013;812. doi: 10.1097/JCMA.0000000000000746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JCMA.0000000000000746</ArticleId><ArticleId IdType="pubmed">35648165</ArticleId></ArticleIdList></Reference><Reference><Citation>Amital H., Szekanecz Z., Sz&#xfc;cs G., Dank&#xf3; K., Nagy E., Cs&#xe9;p&#xe1;ny T., Kiss E., Rovensky J., Tuchynova A., Kozakova D., et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: Is it time to routinely supplement patients with SLE with vitamin D? Ann. Rheum. Dis. 2010;69:1155&#x2013;1157. doi: 10.1136/ard.2009.120329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2009.120329</ArticleId><ArticleId IdType="pubmed">20439290</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruaro B., Casabella A., Paolino S., Alessandri E., Patan&#xe9; M., Gotelli E., Sulli A., Cutolo M. Trabecular Bone Score and Bone Quality in Systemic Lupus Erythematosus Patients. Front. Med. 2020;7:574842. doi: 10.3389/fmed.2020.574842.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.574842</ArticleId><ArticleId IdType="pmc">PMC7554588</ArticleId><ArticleId IdType="pubmed">33102506</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubatan J., Moss A.C. Vitamin D in inflammatory bowel disease: More than just a supplement. Curr. Opin. Gastroenterol. 2018;34:217&#x2013;225. doi: 10.1097/MOG.0000000000000449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOG.0000000000000449</ArticleId><ArticleId IdType="pubmed">29762159</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernia F., Valvano M., Longo S., Cesaro N., Viscido A., Latella G. Vitamin D in Inflammatory Bowel Diseases. Mechanisms of Action and Therapeutic Implications. Nutrients. 2022;14:269. doi: 10.3390/nu14020269.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14020269</ArticleId><ArticleId IdType="pmc">PMC8779654</ArticleId><ArticleId IdType="pubmed">35057450</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierrot-Deseilligny C., Souberbielle J.C. Vitamin D and multiple sclerosis: An update. Mult. Scler. Relat. Disord. 2017;14:35&#x2013;45. doi: 10.1016/j.msard.2017.03.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.msard.2017.03.014</ArticleId><ArticleId IdType="pubmed">28619429</ArticleId></ArticleIdList></Reference><Reference><Citation>Trombetta A.C., Smith V., Gotelli E., Ghio M., Paolino S., Pizzorni C., Vanhaecke A., Ruaro B., Sulli A., Cutolo M. Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments. PLoS ONE. 2017;12:e0179062. doi: 10.1371/journal.pone.0179062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0179062</ArticleId><ArticleId IdType="pmc">PMC5466326</ArticleId><ArticleId IdType="pubmed">28598975</ArticleId></ArticleIdList></Reference><Reference><Citation>Manousaki D., Harroud A., Mitchell R.E., Ross S., Forgetta V., Timpson N.J., Smith G.D., Polychronakos C., Richards J.B. Vitamin D levels and risk of type 1 diabetes: A Mendelian randomization study. PLoS Med. 2021;18:e1003536. doi: 10.1371/journal.pmed.1003536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003536</ArticleId><ArticleId IdType="pmc">PMC7906317</ArticleId><ArticleId IdType="pubmed">33630834</ArticleId></ArticleIdList></Reference><Reference><Citation>Cvek M., Kali&#x10d;anin D., Bari&#x107; A., Vuleti&#x107; M., Gunja&#x10d;a I., Torlak Lovri&#x107; V., &#x160;krabi&#x107; V., Punda A., Boraska Perica V. Vitamin D and Hashimoto&#x2019;s Thyroiditis: Observations from CROHT Biobank. Nutrients. 2021;13:2793. doi: 10.3390/nu13082793.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13082793</ArticleId><ArticleId IdType="pmc">PMC8401592</ArticleId><ArticleId IdType="pubmed">34444953</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikle D.D. Vitamin D and the skin: Physiology and pathophysiology. Rev. Endocr. Metab. Disord. 2012;13:3&#x2013;19. doi: 10.1007/s11154-011-9194-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-011-9194-0</ArticleId><ArticleId IdType="pmc">PMC3687803</ArticleId><ArticleId IdType="pubmed">21845365</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantorna M.T., Snyder L., Arora J. Vitamin A and vitamin D regulate the microbial complexity, barrier function, and the mucosal immune responses to ensure intestinal homeostasis. Crit. Rev. Biochem. Mol. Biol. 2019;54:184&#x2013;192. doi: 10.1080/10409238.2019.1611734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10409238.2019.1611734</ArticleId><ArticleId IdType="pmc">PMC6629036</ArticleId><ArticleId IdType="pubmed">31084433</ArticleId></ArticleIdList></Reference><Reference><Citation>Prietl B., Treiber G., Pieber T.R., Amrein K. Vitamin D and immune function. Nutrients. 2013;5:2502&#x2013;2521. doi: 10.3390/nu5072502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu5072502</ArticleId><ArticleId IdType="pmc">PMC3738984</ArticleId><ArticleId IdType="pubmed">23857223</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismailova A., White J.H. Vitamin D, infections and immunity. Rev. Endocr. Metab. Disord. 2022;23:265&#x2013;277. doi: 10.1007/s11154-021-09679-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-021-09679-5</ArticleId><ArticleId IdType="pmc">PMC8318777</ArticleId><ArticleId IdType="pubmed">34322844</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu F., Zhang Z., Yang L., Li R., Ma Y. Combined effect of vitamin C and vitamin D(3) on intestinal epithelial barrier by regulating Notch signaling pathway. Nutr. Metab. 2021;18:49. doi: 10.1186/s12986-021-00576-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12986-021-00576-x</ArticleId><ArticleId IdType="pmc">PMC8105975</ArticleId><ArticleId IdType="pubmed">33964955</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho J., Chan H., Liang Y., Liu X., Zhang L., Li Q., Zhang Y., Zeng J., Ugwu F.N., Ho I.H.T., et al. Cathelicidin preserves intestinal barrier function in polymicrobial sepsis. Crit. Care. 2020;24:47. doi: 10.1186/s13054-020-2754-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-2754-5</ArticleId><ArticleId IdType="pmc">PMC7011568</ArticleId><ArticleId IdType="pubmed">32041659</ArticleId></ArticleIdList></Reference><Reference><Citation>He L., Liu T., Shi Y., Tian F., Hu H., Deb D.K., Chen Y., Bissonnette M., Li Y.C. Gut Epithelial Vitamin D Receptor Regulates Microbiota-Dependent Mucosal Inflammation by Suppressing Intestinal Epithelial Cell Apoptosis. Endocrinology. 2018;159:967&#x2013;979. doi: 10.1210/en.2017-00748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/en.2017-00748</ArticleId><ArticleId IdType="pmc">PMC5788002</ArticleId><ArticleId IdType="pubmed">29228157</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikle D.D. Vitamin D Regulation of Immune Function. Curr. Osteoporos. Rep. 2022;20:186&#x2013;193. doi: 10.1007/s11914-022-00732-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11914-022-00732-z</ArticleId><ArticleId IdType="pmc">PMC9065668</ArticleId><ArticleId IdType="pubmed">35507293</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewison M., Freeman L., Hughes S.V., Evans K.N., Bland R., Eliopoulos A.G., Kilby M.D., Moss P.A., Chakraverty R. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol. 2003;170:5382&#x2013;5390. doi: 10.4049/jimmunol.170.11.5382.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.170.11.5382</ArticleId><ArticleId IdType="pubmed">12759412</ArticleId></ArticleIdList></Reference><Reference><Citation>Agerberth B., Charo J., Werr J., Olsson B., Idali F., Lindbom L., Kiessling R., Jornvall H., Wigzell H., Gudmundsson G.H. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood. 2000;96:3086&#x2013;3093. doi: 10.1182/blood.V96.9.3086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V96.9.3086</ArticleId><ArticleId IdType="pubmed">11049988</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramanathan B., Davis E.G., Ross C.R., Blecha F. Cathelicidins: Microbicidal activity, mechanisms of action, and roles in innate immunity. Microbes Infect. 2002;4:361&#x2013;372. doi: 10.1016/S1286-4579(02)01549-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1286-4579(02)01549-6</ArticleId><ArticleId IdType="pubmed">11909747</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann B., Rudolph T., Pietzsch J., Meurer M. Conversion of vitamin D3 to 1alpha,25-dihydroxyvitamin D3 in human skin equivalents. Exp. Derm. 2000;9:97&#x2013;103. doi: 10.1034/j.1600-0625.2000.009002097.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0625.2000.009002097.x</ArticleId><ArticleId IdType="pubmed">10772383</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehmann B., Tiebel O., Meurer M. Expression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents--a preliminary study. Arch. Derm. Res. 1999;291:507&#x2013;510. doi: 10.1007/s004030050445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004030050445</ArticleId><ArticleId IdType="pubmed">10541881</ArticleId></ArticleIdList></Reference><Reference><Citation>Korf H., Wenes M., Stijlemans B., Takiishi T., Robert S., Miani M., Eizirik D.L., Gysemans C., Mathieu C. 1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism. Immunobiology. 2012;217:1292&#x2013;1300. doi: 10.1016/j.imbio.2012.07.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2012.07.018</ArticleId><ArticleId IdType="pubmed">22944250</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoffels K., Overbergh L., Giulietti A., Verlinden L., Bouillon R., Mathieu C. Immune regulation of 25-hydroxyvitamin-D3-1alpha-hydroxylase in human monocytes. J. Bone Min. Res. 2006;21:37&#x2013;47. doi: 10.1359/JBMR.050908.</Citation><ArticleIdList><ArticleId IdType="doi">10.1359/JBMR.050908</ArticleId><ArticleId IdType="pubmed">16355272</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber G., Heilborn J.D., Chamorro Jimenez C.I., Hammarsjo A., Torma H., Stahle M. Vitamin D induces the antimicrobial protein hCAP18 in human skin. J. Invest. Dermatol. 2005;124:1080&#x2013;1082. doi: 10.1111/j.0022-202X.2005.23687.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.0022-202X.2005.23687.x</ArticleId><ArticleId IdType="pubmed">15854055</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi K., Nakayama Y., Horiuchi H., Ohta T., Komoriya K., Ohmori H., Kamimura T. Human neutrophils express messenger RNA of vitamin D receptor and respond to 1alpha,25-dihydroxyvitamin D3. Immunopharmacol. Immunotoxicol. 2002;24:335&#x2013;347. doi: 10.1081/IPH-120014721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1081/IPH-120014721</ArticleId><ArticleId IdType="pubmed">12375732</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch D., Archer F.E., Joshi-Kale M., Vetrano A.M., Weinberger B. Decreased anti-inflammatory responses to vitamin D in neonatal neutrophils. Mediat. Inflamm. 2011;2011:598345. doi: 10.1155/2011/598345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/598345</ArticleId><ArticleId IdType="pmc">PMC3246794</ArticleId><ArticleId IdType="pubmed">22219556</ArticleId></ArticleIdList></Reference><Reference><Citation>Bishop E.L., Ismailova A., Dimeloe S., Hewison M., White J.H. Vitamin D and Immune Regulation: Antibacterial, Antiviral, Anti-Inflammatory. JBMR Plus. 2021;5:e10405. doi: 10.1002/jbm4.10405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbm4.10405</ArticleId><ArticleId IdType="pmc">PMC7461279</ArticleId><ArticleId IdType="pubmed">32904944</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinman R.M. Some interfaces of dendritic cell biology. Apmis. 2003;111:675&#x2013;697. doi: 10.1034/j.1600-0463.2003.11107802.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0463.2003.11107802.x</ArticleId><ArticleId IdType="pubmed">12974772</ArticleId></ArticleIdList></Reference><Reference><Citation>Adorini L., Penna G. Induction of tolerogenic dendritic cells by vitamin D receptor agonists. Handb. Exp. Pharm. 2009;188:251&#x2013;273. doi: 10.1007/978-3-540-71029-5_12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-540-71029-5_12</ArticleId><ArticleId IdType="pubmed">19031030</ArticleId></ArticleIdList></Reference><Reference><Citation>Adorini L., Penna G., Giarratana N., Roncari A., Amuchastegui S., Daniel K.C., Uskokovic M. Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands. J. Steroid. Biochem. Mol. Biol. 2004;89&#x2013;90:437&#x2013;441. doi: 10.1016/j.jsbmb.2004.03.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2004.03.013</ArticleId><ArticleId IdType="pubmed">15225816</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonilla F.A., Oettgen H.C. Adaptive immunity. J. Allergy Clin. Immunol. 2010;125:S33&#x2013;S40. doi: 10.1016/j.jaci.2009.09.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2009.09.017</ArticleId><ArticleId IdType="pubmed">20061006</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovely G.A., Sen R. Evolving adaptive immunity. Genes Dev. 2016;30:873&#x2013;875. doi: 10.1101/gad.281014.116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.281014.116</ArticleId><ArticleId IdType="pmc">PMC4840292</ArticleId><ArticleId IdType="pubmed">27083993</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaguchi S. Taking regulatory T cells into medicine. J. Exp. Med. 2021;218:e20210831. doi: 10.1084/jem.20210831.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20210831</ArticleId><ArticleId IdType="pmc">PMC8160581</ArticleId><ArticleId IdType="pubmed">34037676</ArticleId></ArticleIdList></Reference><Reference><Citation>Peelen E., Knippenberg S., Muris A.H., Thewissen M., Smolders J., Tervaert J.W., Hupperts R., Damoiseaux J. Effects of vitamin D on the peripheral adaptive immune system: A review. Autoimmun. Rev. 2011;10:733&#x2013;743. doi: 10.1016/j.autrev.2011.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2011.05.002</ArticleId><ArticleId IdType="pubmed">21621002</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantorna M.T., Snyder L., Lin Y.D., Yang L. Vitamin D and 1,25(OH)2D regulation of T cells. Nutrients. 2015;7:3011&#x2013;3021. doi: 10.3390/nu7043011.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu7043011</ArticleId><ArticleId IdType="pmc">PMC4425186</ArticleId><ArticleId IdType="pubmed">25912039</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldman C.M., Cantorna M.T., DeLuca H.F. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch. Biochem. Biophys. 2000;374:334&#x2013;338. doi: 10.1006/abbi.1999.1605.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/abbi.1999.1605</ArticleId><ArticleId IdType="pubmed">10666315</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Bruce D., Cantorna M.T. Vitamin D receptor expression controls proliferation of na&#xef;ve CD8+ T cells and development of CD8 mediated gastrointestinal inflammation. BMC Immunol. 2014;15:6. doi: 10.1186/1471-2172-15-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2172-15-6</ArticleId><ArticleId IdType="pmc">PMC3923390</ArticleId><ArticleId IdType="pubmed">24502291</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahon B.D., Wittke A., Weaver V., Cantorna M.T. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J. Cell. Biochem. 2003;89:922&#x2013;932. doi: 10.1002/jcb.10580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.10580</ArticleId><ArticleId IdType="pubmed">12874827</ArticleId></ArticleIdList></Reference><Reference><Citation>Provvedini D.M., Tsoukas C.D., Deftos L.J., Manolagas S.C. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science. 1983;221:1181&#x2013;1183. doi: 10.1126/science.6310748.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.6310748</ArticleId><ArticleId IdType="pubmed">6310748</ArticleId></ArticleIdList></Reference><Reference><Citation>Manolagas S.C., Provvedini D.M., Tsoukas C.D. Interactions of 1,25-dihydroxyvitamin D3 and the immune system. Mol. Cell. Endocrinol. 1985;43:113&#x2013;122. doi: 10.1016/0303-7207(85)90074-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0303-7207(85)90074-7</ArticleId><ArticleId IdType="pubmed">3000847</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi J.H., McDaniel K.L., Weaver V., Cantorna M.T. Murine CD8+ T cells but not macrophages express the vitamin D 1&#x3b1;-hydroxylase. J. Nutr. Biochem. 2014;25:58&#x2013;65. doi: 10.1016/j.jnutbio.2013.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2013.09.003</ArticleId><ArticleId IdType="pmc">PMC3857601</ArticleId><ArticleId IdType="pubmed">24314866</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi J.H., Chen J., Cantorna M.T. Vitamin D regulation of immune function in the gut: Why do T cells have vitamin D receptors? Mol. Asp. Med. 2012;33:77&#x2013;82. doi: 10.1016/j.mam.2011.10.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mam.2011.10.014</ArticleId><ArticleId IdType="pmc">PMC3781946</ArticleId><ArticleId IdType="pubmed">22079836</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantorna M.T., Waddell A. The vitamin D receptor turns off chronically activated T cells. Ann. N. Y. Acad. Sci. 2014;1317:70&#x2013;75. doi: 10.1111/nyas.12408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.12408</ArticleId><ArticleId IdType="pubmed">24673331</ArticleId></ArticleIdList></Reference><Reference><Citation>Rafique A., Rejnmark L., Heickendorff L., M&#xf8;ller H.J. 25(OH)D3 and 1.25(OH)2D3 inhibits TNF-&#x3b1; expression in human monocyte derived macrophages. PLoS ONE. 2019;14:e0215383. doi: 10.1371/journal.pone.0215383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0215383</ArticleId><ArticleId IdType="pmc">PMC6461260</ArticleId><ArticleId IdType="pubmed">30978243</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Sims G.P., Chen X.X., Gu Y.Y., Lipsky P.E. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J. Immunol. 2007;179:1634&#x2013;1647. doi: 10.4049/jimmunol.179.3.1634.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.179.3.1634</ArticleId><ArticleId IdType="pubmed">17641030</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemire J.M., Adams J.S., Sakai R., Jordan S.C. 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J. Clin. Invest. 1984;74:657&#x2013;661. doi: 10.1172/JCI111465.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI111465</ArticleId><ArticleId IdType="pmc">PMC370520</ArticleId><ArticleId IdType="pubmed">6611355</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutolo M., Paolino S., Sulli A., Smith V., Pizzorni C., Seriolo B. Vitamin D, steroid hormones, and autoimmunity. Ann. N. Y. Acad. Sci. 2014;1317:39&#x2013;46. doi: 10.1111/nyas.12432.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.12432</ArticleId><ArticleId IdType="pubmed">24739090</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbour G.L., Coburn J.W., Slatopolsky E., Norman A.W., Horst R.L. Hypercalcemia in an anephric patient with sarcoidosis: Evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N. Engl. J. Med. 1981;305:440&#x2013;443. doi: 10.1056/NEJM198108203050807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198108203050807</ArticleId><ArticleId IdType="pubmed">6894783</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouillon R., Marcocci C., Carmeliet G., Bikle D., White J.H., Dawson-Hughes B., Lips P., Munns C.F., Lazaretti-Castro M., Giustina A., et al. Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions. Endocr. Rev. 2019;40:1109&#x2013;1151. doi: 10.1210/er.2018-00126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2018-00126</ArticleId><ArticleId IdType="pmc">PMC6626501</ArticleId><ArticleId IdType="pubmed">30321335</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikle D.D. Extraskeletal actions of vitamin D. Ann. N. Y. Acad. Sci. 2016;1376:29&#x2013;52. doi: 10.1111/nyas.13219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.13219</ArticleId><ArticleId IdType="pmc">PMC5031366</ArticleId><ArticleId IdType="pubmed">27649525</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas J. Vigantol&#x2014;Adolf Windaus and the history of vitamin D. Wurzbg Med. Mitt. 2007;26:144&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">18354894</ArticleId></ArticleIdList></Reference><Reference><Citation>Aaron L., Patricia J., Torsten M. The world incidence and prevalence of autoimmune diseases is increasing. Int. J. Celiac Dis. 2015;3:151&#x2013;155.</Citation></Reference><Reference><Citation>Holick M.F. Vitamin D deficiency. N. Engl. J. Med. 2007;357:266&#x2013;281. doi: 10.1056/NEJMra070553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra070553</ArticleId><ArticleId IdType="pubmed">17634462</ArticleId></ArticleIdList></Reference><Reference><Citation>Badenhoop K., Kahles H., Penna-Martinez M. Vitamin D, immune tolerance, and prevention of type 1 diabetes. Curr. Diab. Rep. 2012;12:635&#x2013;642. doi: 10.1007/s11892-012-0322-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11892-012-0322-3</ArticleId><ArticleId IdType="pubmed">22976537</ArticleId></ArticleIdList></Reference><Reference><Citation>Cyprian F., Lefkou E., Varoudi K., Girardi G. Immunomodulatory Effects of Vitamin D in Pregnancy and Beyond. Front. Immunol. 2019;10:2739. doi: 10.3389/fimmu.2019.02739.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02739</ArticleId><ArticleId IdType="pmc">PMC6883724</ArticleId><ArticleId IdType="pubmed">31824513</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth D.R., Ding N., Parnell G.P., Shahijanian F., Coulter S., Schibeci S.D., Atkins A.R., Stewart G.J., Evans R.M., Downes M., et al. Cistromic and genetic evidence that the vitamin D receptor mediates susceptibility to latitude-dependent autoimmune diseases. Genes Immun. 2016;17:213&#x2013;219. doi: 10.1038/gene.2016.12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2016.12</ArticleId><ArticleId IdType="pmc">PMC4895389</ArticleId><ArticleId IdType="pubmed">26986782</ArticleId></ArticleIdList></Reference><Reference><Citation>Illescas-Montes R., Melguizo-Rodr&#xed;guez L., Ruiz C., Costela-Ruiz V.J. Vitamin D and autoimmune diseases. Life Sci. 2019;233:116744. doi: 10.1016/j.lfs.2019.116744.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2019.116744</ArticleId><ArticleId IdType="pubmed">31401314</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdaca G., Tonacci A., Negrini S., Greco M., Borro M., Puppo F., Gangemi S. Emerging role of vitamin D in autoimmune diseases: An update on evidence and therapeutic implications. Autoimmun. Rev. 2019;18:102350. doi: 10.1016/j.autrev.2019.102350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2019.102350</ArticleId><ArticleId IdType="pubmed">31323357</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M., Sainaghi P.P., Pirisi M. Role of Vitamin D in Rheumatoid Arthritis. Adv. Exp. Med. Biol. 2017;996:155&#x2013;168. doi: 10.1007/978-3-319-56017-5_13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-56017-5_13</ArticleId><ArticleId IdType="pubmed">29124698</ArticleId></ArticleIdList></Reference><Reference><Citation>Bragazzi N.L., Watad A., Neumann S.G., Simon M., Brown S.B., Abu Much A., Harari A., Tiosano S., Amital H., Shoenfeld Y. Vitamin D and rheumatoid arthritis: An ongoing mystery. Curr. Opin. Rheumatol. 2017;29:378&#x2013;388. doi: 10.1097/BOR.0000000000000397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000397</ArticleId><ArticleId IdType="pubmed">28463872</ArticleId></ArticleIdList></Reference><Reference><Citation>Buondonno I., Rovera G., Sassi F., Rigoni M.M., Lomater C., Parisi S., Pellerito R., Isaia G.C., D&#x2019;Amelio P. Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study. PLoS ONE. 2017;12:e0178463. doi: 10.1371/journal.pone.0178463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0178463</ArticleId><ArticleId IdType="pmc">PMC5459341</ArticleId><ArticleId IdType="pubmed">28582403</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishikawa L.L.W., Colavite P.M., Fraga-Silva T.F.C., Mimura L.A.N., Fran&#xe7;a T.G.D., Zorzella-Pezavento S.F.G., Chiuso-Minicucci F., Marcolino L.D., Penitenti M., Ikoma M.R.V., et al. Vitamin D Deficiency and Rheumatoid Arthritis. Clin. Rev. Allergy Immunol. 2017;52:373&#x2013;388. doi: 10.1007/s12016-016-8577-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-016-8577-0</ArticleId><ArticleId IdType="pubmed">27484684</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostoglou-Athanassiou I., Athanassiou P., Lyraki A., Raftakis I., Antoniadis C. Vitamin D and rheumatoid arthritis. Adv. Endocrinol. Metab. 2012;3:181&#x2013;187. doi: 10.1177/2042018812471070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2042018812471070</ArticleId><ArticleId IdType="pmc">PMC3539179</ArticleId><ArticleId IdType="pubmed">23323190</ArticleId></ArticleIdList></Reference><Reference><Citation>Song G.G., Bae S.C., Lee Y.H. Association between vitamin D intake and the risk of rheumatoid arthritis: A meta-analysis. Clin. Rheumatol. 2012;31:1733&#x2013;1739. doi: 10.1007/s10067-012-2080-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-012-2080-7</ArticleId><ArticleId IdType="pubmed">22941259</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis M.L., Pagano M.T., Pierdominici M., Ortona E. The role of vitamin D in autoimmune diseases: Could sex make the difference? Biol. Sex. Differ. 2021;12:12. doi: 10.1186/s13293-021-00358-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-021-00358-3</ArticleId><ArticleId IdType="pmc">PMC7802252</ArticleId><ArticleId IdType="pubmed">33436077</ArticleId></ArticleIdList></Reference><Reference><Citation>Watad A., Neumann S.G., Soriano A., Amital H., Shoenfeld Y. Vitamin D and Systemic Lupus Erythematosus: Myth or Reality? Isr. Med. Assoc. J. 2016;18:177&#x2013;182.</Citation><ArticleIdList><ArticleId IdType="pubmed">27228639</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan S.Y., Cai H.Y., Wang P., Lv T.T., Liu L.N., Mao Y.M., Zhao C.N., Wu Q., Dan Y.L., Sam N.B., et al. Association between circulating 25-hydroxyvitamin D and systemic lupus erythematosus: A systematic review and meta-analysis. Int. J. Rheum. Dis. 2019;22:1803&#x2013;1813. doi: 10.1111/1756-185X.13676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.13676</ArticleId><ArticleId IdType="pubmed">31468723</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok C.C., Birmingham D.J., Leung H.W., Hebert L.A., Song H., Rovin B.H. Vitamin D levels in Chinese patients with systemic lupus erythematosus: Relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology. 2012;51:644&#x2013;652. doi: 10.1093/rheumatology/ker212.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ker212</ArticleId><ArticleId IdType="pubmed">21719424</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae S.C., Lee Y.H. Vitamin D level and risk of systemic lupus erythematosus and rheumatoid arthritis: A Mendelian randomization. Clin. Rheumatol. 2018;37:2415&#x2013;2421. doi: 10.1007/s10067-018-4152-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-018-4152-9</ArticleId><ArticleId IdType="pubmed">29799605</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantorna M.T. Vitamin D and its role in immunology: Multiple sclerosis, and inflammatory bowel disease. Prog. Biophys. Mol. Biol. 2006;92:60&#x2013;64. doi: 10.1016/j.pbiomolbio.2006.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pbiomolbio.2006.02.020</ArticleId><ArticleId IdType="pubmed">16563470</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantorna M.T. Vitamin D, multiple sclerosis and inflammatory bowel disease. Arch. Biochem. Biophys. 2012;523:103&#x2013;106. doi: 10.1016/j.abb.2011.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2011.11.001</ArticleId><ArticleId IdType="pmc">PMC3374859</ArticleId><ArticleId IdType="pubmed">22085500</ArticleId></ArticleIdList></Reference><Reference><Citation>Correale J., Ysrraelit M.C., Gaitan M.I. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain. 2009;132:1146&#x2013;1160. doi: 10.1093/brain/awp033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp033</ArticleId><ArticleId IdType="pubmed">19321461</ArticleId></ArticleIdList></Reference><Reference><Citation>Gianfrancesco M.A., Stridh P., Rhead B., Shao X., Xu E., Graves J.S., Chitnis T., Waldman A., Lotze T., Schreiner T., et al. Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS. Neurology. 2017;88:1623&#x2013;1629. doi: 10.1212/WNL.0000000000003849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003849</ArticleId><ArticleId IdType="pmc">PMC5405763</ArticleId><ArticleId IdType="pubmed">28356466</ArticleId></ArticleIdList></Reference><Reference><Citation>Kragt J., van Amerongen B., Killestein J., Dijkstra C., Uitdehaag B., Polman C., Lips P. Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women. Mult. Scler. 2009;15:9&#x2013;15. doi: 10.1177/1352458508095920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458508095920</ArticleId><ArticleId IdType="pubmed">18701572</ArticleId></ArticleIdList></Reference><Reference><Citation>Hausmann J., Kubesch A., Amiri M., Filmann N., Blumenstein I. Vitamin D Deficiency is Associated with Increased Disease Activity in Patients with Inflammatory Bowel Disease. J. Clin. Med. 2019;8:1319. doi: 10.3390/jcm8091319.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8091319</ArticleId><ArticleId IdType="pmc">PMC6780251</ArticleId><ArticleId IdType="pubmed">31461996</ArticleId></ArticleIdList></Reference><Reference><Citation>Sairenji T., Collins K.L., Evans D.V. An Update on Inflammatory Bowel Disease. Prim. Care. 2017;44:673&#x2013;692. doi: 10.1016/j.pop.2017.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pop.2017.07.010</ArticleId><ArticleId IdType="pubmed">29132528</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza H.S., Fiocchi C. Immunopathogenesis of IBD: Current state of the art. Nat. Rev. Gastroenterol. Hepatol. 2016;13:13&#x2013;27. doi: 10.1038/nrgastro.2015.186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2015.186</ArticleId><ArticleId IdType="pubmed">26627550</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher J., Cooper S.C., Ghosh S., Hewison M. The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management. Nutrients. 2019;11:1019. doi: 10.3390/nu11051019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11051019</ArticleId><ArticleId IdType="pmc">PMC6566188</ArticleId><ArticleId IdType="pubmed">31067701</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Cui X., Li J., Wang H., Li Y., Chen Y., Zhang H. Clinical evaluation of vitamin D status and its relationship with disease activity and changes of intestinal immune function in patients with Crohn&#x2019;s disease in the Chinese population. Scand. J. Gastroenterol. 2021;56:20&#x2013;29. doi: 10.1080/00365521.2020.1844793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365521.2020.1844793</ArticleId><ArticleId IdType="pubmed">33205696</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Weaver V., Smith J.P., Bingaman S., Hartman T.J., Cantorna M.T. Therapeutic effect of vitamin d supplementation in a pilot study of Crohn&#x2019;s patients. Clin. Transl. Gastroenterol. 2013;4:e33. doi: 10.1038/ctg.2013.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ctg.2013.1</ArticleId><ArticleId IdType="pmc">PMC3636524</ArticleId><ArticleId IdType="pubmed">23594800</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemke D., Klement R.J., Schweiger F., Schweiger B., Spitz J. Vitamin D Resistance as a Possible Cause of Autoimmune Diseases: A Hypothesis Confirmed by a Therapeutic High-Dose Vitamin D Protocol. Front. Immunol. 2021;12:655739. doi: 10.3389/fimmu.2021.655739.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.655739</ArticleId><ArticleId IdType="pmc">PMC8058406</ArticleId><ArticleId IdType="pubmed">33897704</ArticleId></ArticleIdList></Reference><Reference><Citation>Merlino L.A., Curtis J., Mikuls T.R., Cerhan J.R., Criswell L.A., Saag K.G. Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women&#x2019;s Health Study. Arthritis Rheum. 2004;50:72&#x2013;77. doi: 10.1002/art.11434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.11434</ArticleId><ArticleId IdType="pubmed">14730601</ArticleId></ArticleIdList></Reference><Reference><Citation>Costenbader K.H., Feskanich D., Holmes M., Karlson E.W., Benito-Garcia E. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann. Rheum. Dis. 2008;67:530&#x2013;535. doi: 10.1136/ard.2007.072736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2007.072736</ArticleId><ArticleId IdType="pmc">PMC2717608</ArticleId><ArticleId IdType="pubmed">17666449</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiraki L.T., Arkema E.V., Cui J., Malspeis S., Costenbader K.H., Karlson E.W. Circulating 25-hydroxyvitamin D level and risk of developing rheumatoid arthritis. Rheumatology. 2014;53:2243&#x2013;2248. doi: 10.1093/rheumatology/keu276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keu276</ArticleId><ArticleId IdType="pmc">PMC4241892</ArticleId><ArticleId IdType="pubmed">25065001</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutolo M., Otsa K., Laas K., Yprus M., Lehtme R., Secchi M.E., Sulli A., Paolino S., Seriolo B. Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin. Exp. Rheumatol. 2006;24:702&#x2013;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">17207389</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutolo M., Otsa K., Uprus M., Paolino S., Seriolo B. Vitamin D in rheumatoid arthritis. Autoimmun. Rev. 2007;7:59&#x2013;64. doi: 10.1016/j.autrev.2007.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2007.07.001</ArticleId><ArticleId IdType="pubmed">17967727</ArticleId></ArticleIdList></Reference><Reference><Citation>Attar S.M. Vitamin D deficiency in rheumatoid arthritis. Prevalence and association with disease activity in Western Saudi Arabia. Saudi Med. J. 2012;33:520&#x2013;525.</Citation><ArticleIdList><ArticleId IdType="pubmed">22588813</ArticleId></ArticleIdList></Reference><Reference><Citation>Baykal T., Senel K., Alp F., Erdal A., Ugur M. Is there an association between serum 25-hydroxyvitamin D concentrations and disease activity in rheumatoid arthritis? Bratisl. Lek. Listy. 2012;113:610&#x2013;611. doi: 10.4149/BLL_2012_137.</Citation><ArticleIdList><ArticleId IdType="doi">10.4149/BLL_2012_137</ArticleId><ArticleId IdType="pubmed">23094901</ArticleId></ArticleIdList></Reference><Reference><Citation>Yazmalar L., Ediz L., Alpayci M., Hiz O., Toprak M., Tekeoglu I. Seasonal disease activity and serum vitamin D levels in rheumatoid arthritis, ankylosing spondylitis and osteoarthritis. Afr. Health Sci. 2013;13:47&#x2013;55. doi: 10.4314/ahs.v13i1.7.</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/ahs.v13i1.7</ArticleId><ArticleId IdType="pmc">PMC3645084</ArticleId><ArticleId IdType="pubmed">23658567</ArticleId></ArticleIdList></Reference><Reference><Citation>Atwa M.A., Balata M.G., Hussein A.M., Abdelrahman N.I., Elminshawy H.H. Serum 25-hydroxyvitamin D concentration in patients with psoriasis and rheumatoid arthritis and its association with disease activity and serum tumor necrosis factor-alpha. Saudi Med. J. 2013;34:806&#x2013;813.</Citation><ArticleIdList><ArticleId IdType="pubmed">23974451</ArticleId></ArticleIdList></Reference><Reference><Citation>Sahebari M., Mirfeizi Z., Rezaieyazdi Z., Rafatpanah H., Goshyeshi L. 25(OH) vitamin D serum values and rheumatoid arthritis disease activity (DA S28 ESR) Casp. J. Intern. Med. 2014;5:148&#x2013;155.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4143736</ArticleId><ArticleId IdType="pubmed">25202442</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheita T.A., Sayed S., Gheita H.A., Kenawy S.A. Vitamin D status in rheumatoid arthritis patients: Relation to clinical manifestations, disease activity, quality of life and fibromyalgia syndrome. Int. J. Rheum. Dis. 2016;19:294&#x2013;299. doi: 10.1111/1756-185X.12426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.12426</ArticleId><ArticleId IdType="pubmed">25291242</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Liu W., Lin Q., Chen L., Yin J., Huang H. Vitamin D deficiency and low bone mineral density in native Chinese rheumatoid arthritis patients. Int. J. Rheum. Dis. 2014;17:66&#x2013;70. doi: 10.1111/1756-185X.12160.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.12160</ArticleId><ArticleId IdType="pubmed">24131858</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong Q., Xu J., Xu S., Lian L., Zhang M., Ding C. Associations between serum 25-hydroxyvitamin D and disease activity, inflammatory cytokines and bone loss in patients with rheumatoid arthritis. Rheumatology. 2014;53:1994&#x2013;2001. doi: 10.1093/rheumatology/keu173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keu173</ArticleId><ArticleId IdType="pubmed">24907153</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R., Saigal R., Goyal L., Mital P., Yadav R.N., Meena P.D., Agrawal A. Estimation of vitamin D levels in rheumatoid arthritis patients and its correlation with the disease activity. J. Assoc. Physicians. India. 2014;62:678&#x2013;681.</Citation><ArticleIdList><ArticleId IdType="pubmed">25856934</ArticleId></ArticleIdList></Reference><Reference><Citation>Brance M.L., Brun L.R., Lioi S., S&#xe1;nchez A., Abdala M., Oliveri B. Vitamin D levels and bone mass in rheumatoid arthritis. Rheumatol. Int. 2015;35:499&#x2013;505. doi: 10.1007/s00296-014-3071-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-014-3071-6</ArticleId><ArticleId IdType="pubmed">24980067</ArticleId></ArticleIdList></Reference><Reference><Citation>Grazio S., Nagli&#x107; &#x110;., Ani&#x107; B., Grubi&#x161;i&#x107; F., Bobek D., Bakula M., Kavanagh H.S., Kuna A.T., Cvijeti&#x107; S. Vitamin D serum level, disease activity and functional ability in different rheumatic patients. Am. J. Med. Sci. 2015;349:46&#x2013;49. doi: 10.1097/MAJ.0000000000000340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAJ.0000000000000340</ArticleId><ArticleId IdType="pubmed">25310509</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen H.Y., Luo J., Li X.F. Vitamin D Levels and Associations With Disease Activity in Chinese Han Patients with Early Rheumatoid Arthritis. J. Clin. Rheumatol. 2015;21:276&#x2013;277. doi: 10.1097/RHU.0000000000000268.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RHU.0000000000000268</ArticleId><ArticleId IdType="pubmed">26203837</ArticleId></ArticleIdList></Reference><Reference><Citation>Senosi M.R., Fathi H.M., Baki N.M.A., Zaki O., Magdy A.M., Gheita T.A. Bone mineral density, vitamin D receptor (VDR) gene polymorphisms, fracture risk assessment (FRAX), and trabecular bone score (TBS) in rheumatoid arthritis patients: Connecting pieces of the puzzle. Clin. Rheumatol. 2022;41:1333&#x2013;1342. doi: 10.1007/s10067-022-06048-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-022-06048-8</ArticleId><ArticleId IdType="pmc">PMC9056478</ArticleId><ArticleId IdType="pubmed">35048212</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin J., Liu J., Davies M.L., Chen W. Serum Vitamin D Level and Rheumatoid Arthritis Disease Activity: Review and Meta-Analysis. PLoS ONE. 2016;11:e0146351. doi: 10.1371/journal.pone.0146351.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0146351</ArticleId><ArticleId IdType="pmc">PMC4709104</ArticleId><ArticleId IdType="pubmed">26751969</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannini D., Antonucci M., Petrelli F., Bilia S., Alunno A., Puxeddu I. One year in review 2020: Pathogenesis of rheumatoid arthritis. Clin. Exp. Rheumatol. 2020;38:387&#x2013;397. doi: 10.55563/clinexprheumatol/3uj1ng.</Citation><ArticleIdList><ArticleId IdType="doi">10.55563/clinexprheumatol/3uj1ng</ArticleId><ArticleId IdType="pubmed">32324123</ArticleId></ArticleIdList></Reference><Reference><Citation>McInnes I.B., Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 2017;389:2328&#x2013;2337. doi: 10.1016/S0140-6736(17)31472-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31472-1</ArticleId><ArticleId IdType="pubmed">28612747</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao D.A., Gurish M.F., Marshall J.L., Slowikowski K., Fonseka C.Y., Liu Y., Donlin L.T., Henderson L.A., Wei K., Mizoguchi F., et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542:110&#x2013;114. doi: 10.1038/nature20810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20810</ArticleId><ArticleId IdType="pmc">PMC5349321</ArticleId><ArticleId IdType="pubmed">28150777</ArticleId></ArticleIdList></Reference><Reference><Citation>Wehr P., Purvis H., Law S.C., Thomas R. Dendritic cells, T cells and their interaction in rheumatoid arthritis. Clin. Exp. Immunol. 2019;196:12&#x2013;27. doi: 10.1111/cei.13256.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cei.13256</ArticleId><ArticleId IdType="pmc">PMC6422662</ArticleId><ArticleId IdType="pubmed">30589082</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkov M., van Schie K.A., van der Woude D. Autoantibodies and B Cells: The ABC of rheumatoid arthritis pathophysiology. Immunol. Rev. 2020;294:148&#x2013;163. doi: 10.1111/imr.12829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12829</ArticleId><ArticleId IdType="pmc">PMC7065213</ArticleId><ArticleId IdType="pubmed">31845355</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins M.J., Mackie S.L., Thalayasingam N., Bingham S.J., Hamilton J., Kelly C.A. The effect of vitamin D levels on the assessment of disease activity in rheumatoid arthritis. Clin. Rheumatol. 2013;32:863&#x2013;867. doi: 10.1007/s10067-013-2174-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-013-2174-x</ArticleId><ArticleId IdType="pubmed">23340834</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis G., Jr., Holweg C.T., Kummerfeld S.K., Choy D.F., Setiadi A.F., Hackney J.A., Haverty P.M., Gilbert H., Lin W.Y., Diehl L., et al. Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics. Arthritis Res. 2014;16:R90. doi: 10.1186/ar4555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar4555</ArticleId><ArticleId IdType="pmc">PMC4060385</ArticleId><ArticleId IdType="pubmed">25167216</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoenfeld Y., Giacomelli R., Azrielant S., Berardicurti O., Reynolds J.A., Bruce I.N. Vitamin D and systemic lupus erythematosus&#x2014;The hype and the hope. Autoimmun. Rev. 2018;17:19&#x2013;23. doi: 10.1016/j.autrev.2017.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2017.11.004</ArticleId><ArticleId IdType="pubmed">29108830</ArticleId></ArticleIdList></Reference><Reference><Citation>Perricone C., Agmon-Levin N., Colafrancesco S., Shoenfeld Y. Vitamins and systemic lupus erythematosus: To D or not to D. Expert. Rev. Clin. Immunol. 2013;9:397&#x2013;399. doi: 10.1586/eci.13.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/eci.13.23</ArticleId><ArticleId IdType="pubmed">23634733</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam M.A., Khandker S.S., Alam S.S., Kotyla P., Hassan R. Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis. Autoimmun. Rev. 2019;18:102392. doi: 10.1016/j.autrev.2019.102392.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2019.102392</ArticleId><ArticleId IdType="pubmed">31520805</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak A. The Impact of Vitamin D on the Immunopathophysiology, Disease Activity, and Extra-Musculoskeletal Manifestations of Systemic Lupus Erythematosus. Int. J. Mol. Sci. 2018;19:2355. doi: 10.3390/ijms19082355.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19082355</ArticleId><ArticleId IdType="pmc">PMC6121378</ArticleId><ArticleId IdType="pubmed">30103428</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok C.C. Vitamin D and systemic lupus erythematosus: An update. Expert. Rev. Clin. Immunol. 2013;9:453&#x2013;463. doi: 10.1586/eci.13.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/eci.13.19</ArticleId><ArticleId IdType="pubmed">23634739</ArticleId></ArticleIdList></Reference><Reference><Citation>Stagi S., Rigante D. Vitamin D and juvenile systemic lupus erythematosus: Lights, shadows and still unresolved issues. Autoimmun. Rev. 2018;17:290&#x2013;300. doi: 10.1016/j.autrev.2018.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2018.01.004</ArticleId><ArticleId IdType="pubmed">29353100</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap K.S., Morand E.F. Vitamin D and systemic lupus erythematosus: Continued evolution. Int. J. Rheum. Dis. 2015;18:242&#x2013;249. doi: 10.1111/1756-185X.12489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.12489</ArticleId><ArticleId IdType="pubmed">25522756</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Irastorza G., Egurbide M.V., Olivares N., Martinez-Berriotxoa A., Aguirre C. Vitamin D deficiency in systemic lupus erythematosus: Prevalence, predictors and clinical consequences. Rheumatology. 2008;47:920&#x2013;923. doi: 10.1093/rheumatology/ken121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ken121</ArticleId><ArticleId IdType="pubmed">18411213</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahin D., El-Farahaty R.M., Houssen M.E., Machaly S.A., Sallam M., ElSaid T.O., Neseem N.O. Serum 25-OH vitamin D level in treatment-na&#xef;ve systemic lupus erythematosus patients: Relation to disease activity, IL-23 and IL-17. Lupus. 2017;26:917&#x2013;926. doi: 10.1177/0961203316682095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316682095</ArticleId><ArticleId IdType="pubmed">27927883</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao H.H., Tang S.M., Wang Z.M., Zhang X., Chen X.Y., Gao L., Liu J., Dai Y.J., Hu Z.H., Zhang X.W., et al. Study of bone mineral density and serum bone turnover markers in newly diagnosed systemic lupus erythematosus patients. Beijing Da Xue Xue Bao Yi Xue Ban. 2018;50:998&#x2013;1003.</Citation><ArticleIdList><ArticleId IdType="pubmed">30562771</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamen D.L., Cooper G.S., Bouali H., Shaftman S.R., Hollis B.W., Gilkeson G.S. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun. Rev. 2006;5:114&#x2013;117. doi: 10.1016/j.autrev.2005.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2005.05.009</ArticleId><ArticleId IdType="pubmed">16431339</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogaczewicz J., Sysa-Jedrzejowska A., Arkuszewska C., Zabek J., Kontny E., McCauliffe D., Wozniacka A. Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters. Lupus. 2012;21:477&#x2013;484. doi: 10.1177/0961203311427549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203311427549</ArticleId><ArticleId IdType="pubmed">22065093</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae S.C., Lee Y.H. Association between Vitamin D level and/or deficiency, and systemic lupus erythematosus: A meta-analysis. Cell. Mol. Biol. 2018;64:7&#x2013;13. doi: 10.14715/cmb/2018.64.1.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.14715/cmb/2018.64.1.2</ArticleId><ArticleId IdType="pubmed">29412807</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkar M.K., Hile G.A., Tsoi L.C., Xing X., Liu J., Liang Y., Berthier C.C., Swindell W.R., Patrick M.T., Shao S., et al. Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa. Ann. Rheum. Dis. 2018;77:1653&#x2013;1664. doi: 10.1136/annrheumdis-2018-213197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2018-213197</ArticleId><ArticleId IdType="pmc">PMC6185784</ArticleId><ArticleId IdType="pubmed">30021804</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahluwalia J., Marsch A. Photosensitivity and photoprotection in patients with lupus erythematosus. Lupus. 2019;28:697&#x2013;702. doi: 10.1177/0961203319839486.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203319839486</ArticleId><ArticleId IdType="pubmed">31023132</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein R.G., Arnaud S.B., Gallagher J.C., Deluca H.F., Riggs B.L. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose. J. Clin. Invest. 1977;60:253&#x2013;259. doi: 10.1172/JCI108762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI108762</ArticleId><ArticleId IdType="pmc">PMC372363</ArticleId><ArticleId IdType="pubmed">874087</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Leary T.J., Jones G., Yip A., Lohnes D., Cohanim M., Yendt E.R. The effects of chloroquine on serum 1,25-dihydroxyvitamin D and calcium metabolism in sarcoidosis. N. Engl. J. Med. 1986;315:727&#x2013;730. doi: 10.1056/NEJM198609183151203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198609183151203</ArticleId><ArticleId IdType="pubmed">3755800</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho J.F., Blank M., Kiss E., Tarr T., Amital H., Shoenfeld Y. Anti-vitamin D, vitamin D in SLE: Preliminary results. Ann. N. Y. Acad. Sci. 2007;1109:550&#x2013;557. doi: 10.1196/annals.1398.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1398.061</ArticleId><ArticleId IdType="pubmed">17785344</ArticleId></ArticleIdList></Reference><Reference><Citation>Julkunen H., Ekblom-Kullberg S., Miettinen A. Nonrenal and renal activity of systemic lupus erythematosus: A comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4. Rheumatol. Int. 2012;32:2445&#x2013;2451. doi: 10.1007/s00296-011-1962-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-011-1962-3</ArticleId><ArticleId IdType="pubmed">21706294</ArticleId></ArticleIdList></Reference><Reference><Citation>Athanassiou L., Kostoglou-Athanassiou I., Tsakiridis P., Devetzi E., Mavroudi M., Fytas P., Koutsilieris M., Athanassiou P. Vitamin D levels in Greek patients with systemic lupus erythematosus. Lupus. 2022;31:125&#x2013;132. doi: 10.1177/09612033211066462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033211066462</ArticleId><ArticleId IdType="pubmed">35006029</ArticleId></ArticleIdList></Reference><Reference><Citation>Abediazar S., Jafari-Nakhjavani M., Ghorbanihaghjo A., Shekarchi M., Zununi Vahed S. Serum Levels of CXCL10 and Vitamin D in Patients with Lupus Nephritis. Iran J. Kidney Dis. 2019;13:389&#x2013;397.</Citation><ArticleIdList><ArticleId IdType="pubmed">31880585</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Zhang S., Liu J.S., Gui M., Zhang H. Expression of vitamin D receptor in renal tissue of lupus nephritis and its association with renal injury activity. Lupus. 2019;28:290&#x2013;294. doi: 10.1177/0961203319826704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203319826704</ArticleId><ArticleId IdType="pubmed">30691345</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin J., Ye M., Zhao L., Zou W., Shen W., Zhang H., Gong J., He Q. The novel involvement of podocyte autophagic activity in the pathogenesis of lupus nephritis. Histol. Histopathol. 2018;33:803&#x2013;814. doi: 10.14670/hh-11-974.</Citation><ArticleIdList><ArticleId IdType="doi">10.14670/hh-11-974</ArticleId><ArticleId IdType="pubmed">29446059</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Q., Qiao Y., Liu D., Liu F., Gao C., Duan J., Liang L., Di X., Yuan Y., Gao Y., et al. Vitamin D protects podocytes from autoantibodies induced injury in lupus nephritis by reducing aberrant autophagy. Arthritis Res. Ther. 2019;21:19. doi: 10.1186/s13075-018-1803-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-018-1803-9</ArticleId><ArticleId IdType="pmc">PMC6330406</ArticleId><ArticleId IdType="pubmed">30635032</ArticleId></ArticleIdList></Reference><Reference><Citation>Monticielo O.A., Teixeira Tde M., Chies J.A., Brenol J.C., Xavier R.M. Vitamin D and polymorphisms of VDR gene in patients with systemic lupus erythematosus. Clin. Rheumatol. 2012;31:1411&#x2013;1421. doi: 10.1007/s10067-012-2021-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-012-2021-5</ArticleId><ArticleId IdType="pubmed">22692397</ArticleId></ArticleIdList></Reference><Reference><Citation>de Azev&#xea;do Silva J., Monteiro Fernandes K., Tr&#xe9;s Pancotto J.A., Sotero Fragoso T., Donadi E.A., Crovella S., Sandrin-Garcia P. Vitamin D receptor (VDR) gene polymorphisms and susceptibility to systemic lupus erythematosus clinical manifestations. Lupus. 2013;22:1110&#x2013;1117. doi: 10.1177/0961203313500549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203313500549</ArticleId><ArticleId IdType="pubmed">23945129</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreoli L., Dall&#x2019;Ara F., Piantoni S., Zanola A., Piva N., Cutolo M., Tincani A. A 24-month prospective study on the efficacy and safety of two different monthly regimens of vitamin D supplementation in pre-menopausal women with systemic lupus erythematosus. Lupus. 2015;24:499&#x2013;506. doi: 10.1177/0961203314559089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314559089</ArticleId><ArticleId IdType="pubmed">25801893</ArticleId></ArticleIdList></Reference><Reference><Citation>Aranow C., Kamen D.L., Dall&#x2019;Era M., Massarotti E.M., Mackay M.C., Koumpouras F., Coca A., Chatham W.W., Clowse M.E., Criscione-Schreiber L.G., et al. Randomized, Double-Blind, Placebo-Controlled Trial of the Effect of Vitamin D3 on the Interferon Signature in Patients With Systemic Lupus Erythematosus. Arthritis Rheumatol. 2015;67:1848&#x2013;1857. doi: 10.1002/art.39108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39108</ArticleId><ArticleId IdType="pmc">PMC4732716</ArticleId><ArticleId IdType="pubmed">25777546</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimzadeh H., Shirzadi M., Karimifar M. The effect of Vitamin D supplementation in disease activity of systemic lupus erythematosus patients with Vitamin D deficiency: A randomized clinical trial. J. Res. Med. Sci. 2017;22:4. doi: 10.4103/1735-1995.199089.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1735-1995.199089</ArticleId><ArticleId IdType="pmc">PMC5361443</ArticleId><ArticleId IdType="pubmed">28400826</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinho A., Carvalho C., Boleixa D., Bettencourt A., Leal B., Guimar&#xe3;es J., Neves E., Oliveira J.C., Almeida I., Farinha F., et al. Vitamin D supplementation effects on FoxP3 expression in T cells and FoxP3(+)/IL-17A ratio and clinical course in systemic lupus erythematosus patients: A study in a Portuguese cohort. Immunol. Res. 2017;65:197&#x2013;206. doi: 10.1007/s12026-016-8829-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12026-016-8829-3</ArticleId><ArticleId IdType="pubmed">27423437</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Kushi A.G., Azzeh F.S., Header E.A., ElSawy N.A., Hijazi H.H., Jazar A.S., Ghaith M.M., Alarjah M.A. Effect of Vitamin D and Calcium Supplementation in Patients with Systemic Lupus Erythematosus. Saudi J. Med. Med. Sci. 2018;6:137&#x2013;142. doi: 10.4103/sjmms.sjmms_134_17.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/sjmms.sjmms_134_17</ArticleId><ArticleId IdType="pmc">PMC6196696</ArticleId><ArticleId IdType="pubmed">30787840</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro R., Saliba C., Camilleri L., Scerri C., Borg A.A. Vitamin D supplementation in systemic lupus erythematosus: Relationship to disease activity, fatigue and the interferon signature gene expression. BMC Rheumatol. 2021;5:53. doi: 10.1186/s41927-021-00223-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41927-021-00223-1</ArticleId><ArticleId IdType="pmc">PMC8641172</ArticleId><ArticleId IdType="pubmed">34857051</ArticleId></ArticleIdList></Reference><Reference><Citation>Kavadichanda C., Singh P., Maurya S., Tota S., Kiroubagarin A., Kounassegarane D., Anand S., Negi V.S., Aggarwal A. Clinical and serological association of plasma 25-hydroxyvitamin D (25(OH)D) levels in lupus and the short-term effects of oral vitamin D supplementation. Arthritis Res. 2023;25:2. doi: 10.1186/s13075-022-02976-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-022-02976-7</ArticleId><ArticleId IdType="pmc">PMC9807987</ArticleId><ArticleId IdType="pubmed">36597127</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong W., Tang Y., Tang K., Yan Z., Liu T., Tao Q., Wang J., Liu J., Yan X. Leukemia inhibitory factor is dysregulated in ankylosing spondylitis and contributes to bone formation. Int. J. Rheum. Dis. 2022;25:592&#x2013;600. doi: 10.1111/1756-185X.14312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.14312</ArticleId><ArticleId IdType="pubmed">35238474</ArticleId></ArticleIdList></Reference><Reference><Citation>Ben-Shabat N., Watad A., Shabat A., Bragazzi N.L., Comaneshter D., Cohen A.D., Amital H. Low Vitamin D Levels Predict Mortality in Ankylosing Spondylitis Patients: A Nationwide Population-Based Cohort Study. Nutrients. 2020;12:1400. doi: 10.3390/nu12051400.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12051400</ArticleId><ArticleId IdType="pmc">PMC7285142</ArticleId><ArticleId IdType="pubmed">32414130</ArticleId></ArticleIdList></Reference><Reference><Citation>Durmus B., Altay Z., Baysal O., Ersoy Y. Does vitamin D affect disease severity in patients with ankylosing spondylitis? Chin. Med. J. 2012;125:2511&#x2013;2515.</Citation><ArticleIdList><ArticleId IdType="pubmed">22882931</ArticleId></ArticleIdList></Reference><Reference><Citation>Lange U., Teichmann J., Strunk J., M&#xfc;ller-Ladner U., Schmidt K.L. Association of 1.25 vitamin D3 deficiency, disease activity and low bone mass in ankylosing spondylitis. Osteoporos. Int. 2005;16:1999&#x2013;2004. doi: 10.1007/s00198-005-1990-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00198-005-1990-5</ArticleId><ArticleId IdType="pubmed">16172800</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai G., Wang L., Fan D., Xin L., Liu L., Hu Y., Ding N., Xu S., Xia G., Jin X., et al. Vitamin D in ankylosing spondylitis: Review and meta-analysis. Clin. Chim. Acta. 2015;438:316&#x2013;322. doi: 10.1016/j.cca.2014.08.040.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2014.08.040</ArticleId><ArticleId IdType="pubmed">25199851</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang J., Shao M., Wu X. Vitamin D and risk of ankylosing spondylitis: A two-sample mendelian randomization study. Hum. Immunol. 2022;83:81&#x2013;85. doi: 10.1016/j.humimm.2021.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2021.09.003</ArticleId><ArticleId IdType="pubmed">34521568</ArticleId></ArticleIdList></Reference><Reference><Citation>Touma Z., Eder L., Zisman D., Feld J., Chandran V., Rosen C.F., Shen H., Cook R.J., Gladman D.D. Seasonal variation in vitamin D levels in psoriatic arthritis patients from different latitudes and its association with clinical outcomes. Arthritis Care Res. 2011;63:1440&#x2013;1447. doi: 10.1002/acr.20530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.20530</ArticleId><ArticleId IdType="pubmed">22121512</ArticleId></ArticleIdList></Reference><Reference><Citation>Kincse G., Bhattoa P.H., Her&#xe9;di E., Varga J., Szegedi A., K&#xe9;ri J., Ga&#xe1;l J. Vitamin D3 levels and bone mineral density in patients with psoriasis and/or psoriatic arthritis. J. Derm. 2015;42:679&#x2013;684. doi: 10.1111/1346-8138.12876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1346-8138.12876</ArticleId><ArticleId IdType="pubmed">25959376</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamonal S.B.L., Gamonal A.C.C., Marques N.C.V., Brand&#xe3;o M.A.F., Raposo N.R.B. Is vitamin D status relevant to psoriasis and psoriatic arthritis? A retrospective cross-sectional study. Sao Paulo Med. J. 2022;141:e2022216. doi: 10.1590/1516-3180.2022.0216.r1.01072022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1516-3180.2022.0216.r1.01072022</ArticleId><ArticleId IdType="pmc">PMC10065110</ArticleId><ArticleId IdType="pubmed">36214524</ArticleId></ArticleIdList></Reference><Reference><Citation>Theodoridis X., Grammatikopoulou M.G., Stamouli E.M., Talimtzi P., Pagkalidou E., Zafiriou E., Haidich A.B., Bogdanos D.P. Effectiveness of oral vitamin D supplementation in lessening disease severity among patients with psoriasis: A systematic review and meta-analysis of randomized controlled trials. Nutrition. 2021;82:111024. doi: 10.1016/j.nut.2020.111024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2020.111024</ArticleId><ArticleId IdType="pubmed">33183899</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldini C., Delle Sedie A., Luciano N., Pepe P., Ferro F., Talarico R., Tani C., Mosca M. Vitamin D in &#x201c;early&#x201d; primary Sj&#xf6;gren&#x2019;s syndrome: Does it play a role in influencing disease phenotypes? Rheumatol. Int. 2014;34:1159&#x2013;1164. doi: 10.1007/s00296-013-2872-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-013-2872-3</ArticleId><ArticleId IdType="pubmed">24097207</ArticleId></ArticleIdList></Reference><Reference><Citation>Erten &#x15e;., &#x15e;ahin A., Altuno&#x11f;lu A., Gemcio&#x11f;lu E., Koca C. Comparison of plasma vitamin D levels in patients with Sj&#xf6;gren&#x2019;s syndrome and healthy subjects. Int. J. Rheum. Dis. 2015;18:70&#x2013;75. doi: 10.1111/1756-185X.12298.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.12298</ArticleId><ArticleId IdType="pubmed">24467766</ArticleId></ArticleIdList></Reference><Reference><Citation>Zardi E.M., Basta F., Afeltra A. Levels of Vitamin D, Disease Activity and Subclinical Atherosclerosis in Post-menopausal Women with Sj&#xf6;gren&#x2019;s Syndrome: Does a Link Exist? Vivo. 2016;30:721&#x2013;725.</Citation><ArticleIdList><ArticleId IdType="pubmed">27566098</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L., Chen J., Jiang Y. The association between vitamin D level and Sj&#xf6;gren&#x2019;s syndrome: A meta-analysis. Int. J. Rheum. Dis. 2019;22:532&#x2013;533. doi: 10.1111/1756-185X.13474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.13474</ArticleId><ArticleId IdType="pubmed">30729692</ArticleId></ArticleIdList></Reference><Reference><Citation>Agmon-Levin N., Kivity S., Tzioufas A.G., L&#xf3;pez Hoyos M., Rozman B., Efes I., Shapira Y., Shamis A., Amital H., Youinou P., et al. Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sj&#xf6;gren&#x2019;s syndrome. J. Autoimmun. 2012;39:234&#x2013;239. doi: 10.1016/j.jaut.2012.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2012.05.018</ArticleId><ArticleId IdType="pubmed">22835660</ArticleId></ArticleIdList></Reference><Reference><Citation>Piera-Velazquez S., Wermuth P.J., Gomez-Reino J.J., Varga J., Jimenez S.A. Chemical exposure-induced systemic fibrosing disorders: Novel insights into systemic sclerosis etiology and pathogenesis. Semin. Arthritis Rheum. 2020;50:1226&#x2013;1237. doi: 10.1016/j.semarthrit.2020.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2020.09.003</ArticleId><ArticleId IdType="pubmed">33059296</ArticleId></ArticleIdList></Reference><Reference><Citation>Schinke S., Riemekasten G. Systemic sclerosis. Internist. 2019;60:1251&#x2013;1269. doi: 10.1007/s00108-019-00699-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00108-019-00699-7</ArticleId><ArticleId IdType="pubmed">31754753</ArticleId></ArticleIdList></Reference><Reference><Citation>Denton C.P. Advances in pathogenesis and treatment of systemic sclerosis. Clin. Med. 2015;15((Suppl. S6)):s58&#x2013;s63. doi: 10.7861/clinmedicine.15-6-s58.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmedicine.15-6-s58</ArticleId><ArticleId IdType="pubmed">26634684</ArticleId></ArticleIdList></Reference><Reference><Citation>Elhai M., Avouac J., Kahan A., Allanore Y. Systemic sclerosis: Recent insights. Jt. Bone Spine. 2015;82:148&#x2013;153. doi: 10.1016/j.jbspin.2014.10.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2014.10.010</ArticleId><ArticleId IdType="pubmed">25557659</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearson D.R., Werth V.P., Pappas-Taffer L. Systemic sclerosis: Current concepts of skin and systemic manifestations. Clin. Derm. 2018;36:459&#x2013;474. doi: 10.1016/j.clindermatol.2018.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clindermatol.2018.04.004</ArticleId><ArticleId IdType="pubmed">30047430</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanatta E., Codullo V., Avouac J., Allanore Y. Systemic sclerosis: Recent insight in clinical management. Jt. Bone Spine. 2020;87:293&#x2013;299. doi: 10.1016/j.jbspin.2019.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbspin.2019.09.015</ArticleId><ArticleId IdType="pubmed">31568838</ArticleId></ArticleIdList></Reference><Reference><Citation>Groseanu L., Bojinca V., Gudu T., Saulescu I., Predeteanu D., Balanescu A., Berghea F., Opris D., Borangiu A., Constantinescu C., et al. Low vitamin D status in systemic sclerosis and the impact on disease phenotype. Eur. J. Rheumatol. 2016;3:50&#x2013;55. doi: 10.5152/eurjrheum.2015.0065.</Citation><ArticleIdList><ArticleId IdType="doi">10.5152/eurjrheum.2015.0065</ArticleId><ArticleId IdType="pmc">PMC5042230</ArticleId><ArticleId IdType="pubmed">27708971</ArticleId></ArticleIdList></Reference><Reference><Citation>Runowska M., Majewski D., Majewska K., Puszczewicz M. Vitamin D supply in patients with rheumatic diseases in Poland&#x2014;A pilot study. Reumatologia. 2021;59:146&#x2013;152. doi: 10.5114/reum.2021.107430.</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/reum.2021.107430</ArticleId><ArticleId IdType="pmc">PMC8436800</ArticleId><ArticleId IdType="pubmed">34538941</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnson Y., Amital H., Agmon-Levin N., Alon D., S&#xe1;nchez-Casta&#xf1;&#xf3;n M., L&#xf3;pez-Hoyos M., Matucci-Cerinic M., Sz&#xfc;cs G., Shapira Y., Szekanecz Z., et al. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: A retrospective cohort study and review of the literature. Autoimmun. Rev. 2011;10:490&#x2013;494. doi: 10.1016/j.autrev.2011.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2011.02.002</ArticleId><ArticleId IdType="pubmed">21320645</ArticleId></ArticleIdList></Reference><Reference><Citation>Perazzi M., Gallina E., Manfredi G.F., Patrucco F., Acquaviva A., Colangelo D., Pirisi M., Bellan M. Vitamin D in Systemic Sclerosis: A Review. Nutrients. 2022;14:3908. doi: 10.3390/nu14193908.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14193908</ArticleId><ArticleId IdType="pmc">PMC9573213</ArticleId><ArticleId IdType="pubmed">36235561</ArticleId></ArticleIdList></Reference><Reference><Citation>Slominski A.T., Li W., Bhattacharya S.K., Smith R.A., Johnson P.L., Chen J., Nelson K.E., Tuckey R.C., Miller D., Jiao Y., et al. Vitamin D analogs 17,20S(OH)2pD and 17,20R(OH)2pD are noncalcemic and exhibit antifibrotic activity. J. Invest. Dermatol. 2011;131:1167&#x2013;1169. doi: 10.1038/jid.2010.425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jid.2010.425</ArticleId><ArticleId IdType="pmc">PMC3078214</ArticleId><ArticleId IdType="pubmed">21228816</ArticleId></ArticleIdList></Reference><Reference><Citation>Zerr P., Vollath S., Palumbo-Zerr K., Tomcik M., Huang J., Distler A., Beyer C., Dees C., Gela K., Distler O., et al. Vitamin D receptor regulates TGF-&#x3b2; signalling in systemic sclerosis. Ann. Rheum. Dis. 2015;74:e20. doi: 10.1136/annrheumdis-2013-204378.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-204378</ArticleId><ArticleId IdType="pubmed">24448349</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Liberto D., Scazzone C., La Rocca G., Cipriani P., Lo Pizzo M., Ruscitti P., Agnello L., Ciaccio M., Dieli F., Giacomelli R., et al. Vitamin D increases the production of IL-10 by regulatory T cells in patients with systemic sclerosis. Clin. Exp. Rheumatol. 2019;37((Suppl. S119)):76&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">31587692</ArticleId></ArticleIdList></Reference><Reference><Citation>Atteritano M., Sorbara S., Bagnato G., Miceli G., Sangari D., Morgante S., Visalli E. Bone mineral density, bone turnover markers and fractures in patients with systemic sclerosis: A case control study. PLoS ONE. 2013;8:e66991. doi: 10.1371/journal.pone.0066991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0066991</ArticleId><ArticleId IdType="pmc">PMC3688576</ArticleId><ArticleId IdType="pubmed">23818972</ArticleId></ArticleIdList></Reference><Reference><Citation>Atteritano M., Santoro D., Corallo G., Visalli E., Buemi M., Catalano A., Lasco A., Bitto A., Squadrito F. Skin Involvement and Pulmonary Hypertension Are Associated with Vitamin D Insufficiency in Scleroderma. Int. J. Mol. Sci. 2016;17:2103. doi: 10.3390/ijms17122103.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms17122103</ArticleId><ArticleId IdType="pmc">PMC5187903</ArticleId><ArticleId IdType="pubmed">27983651</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrado A., Colia R., Mele A., Di Bello V., Trotta A., Neve A., Cantatore F.P. Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis. PLoS ONE. 2015;10:e0137912. doi: 10.1371/journal.pone.0137912.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0137912</ArticleId><ArticleId IdType="pmc">PMC4572708</ArticleId><ArticleId IdType="pubmed">26375284</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Duan Y., Zhang T.P., Huang X.L., Li B.Z., Ye D.Q., Wang J. Association between the serum level of vitamin D and systemic sclerosis in a Chinese population: A case control study. Int. J. Rheum. Dis. 2017;20:1002&#x2013;1008. doi: 10.1111/1756-185X.12794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.12794</ArticleId><ArticleId IdType="pubmed">26619796</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmadi R., Hajialilo M., Ghorbanihaghjo A., Mota A., Raeisi S., Bargahi N., Valilo M., Askarian F. FGF-23, Klotho and Vitamin D Levels in Scleroderma. Iran J. Public Health. 2017;46:530&#x2013;536.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5439043</ArticleId><ArticleId IdType="pubmed">28540270</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajialilo M., Noorabadi P., Tahsini Tekantapeh S., Malek Mahdavi A. Endothelin-1, &#x3b1;-Klotho, 25(OH) Vit D levels and severity of disease in scleroderma patients. Rheumatol. Int. 2017;37:1651&#x2013;1657. doi: 10.1007/s00296-017-3797-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-017-3797-z</ArticleId><ArticleId IdType="pubmed">28831601</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S., Mahajan V.K., Yadav R.S., Mehta K.S., Bhushan S., Chauhan P.S., Rawat R., Sharma V. Evaluation of Serum Vitamin D Levels in Patients with Systemic Sclerosis and Healthy Controls: Results of a Pilot Study. Indian Derm. Online J. 2018;9:250&#x2013;255. doi: 10.4103/idoj.IDOJ_328_17.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/idoj.IDOJ_328_17</ArticleId><ArticleId IdType="pmc">PMC6042194</ArticleId><ArticleId IdType="pubmed">30050814</ArticleId></ArticleIdList></Reference><Reference><Citation>Hax V., Gasparin A.A., Schneider L., Monticielo O.A., Soares H.M.F., Streit M.D.A., Pfaffenseller B., Xavier R.M., Chakr R. Vitamin D and Cytokine Profiles in Patients with Systemic Sclerosis. J. Clin. Rheumatol. 2020;26:289&#x2013;294. doi: 10.1097/RHU.0000000000001112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RHU.0000000000001112</ArticleId><ArticleId IdType="pubmed">31397760</ArticleId></ArticleIdList></Reference><Reference><Citation>Horv&#xe1;th &#xc1;., V&#xe9;gh E., Pusztai A., Peth&#x151; Z., Hamar A., Cz&#xf3;kolyov&#xe1; M., Bhattoa H.P., Nagy G., Juh&#xe1;sz B., Hodosi K., et al. Complex assessment of bone mineral density, fracture risk, vitamin D status, and bone metabolism in Hungarian systemic sclerosis patients. Arthritis Res. 2019;21:274. doi: 10.1186/s13075-019-2072-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-019-2072-y</ArticleId><ArticleId IdType="pmc">PMC6905018</ArticleId><ArticleId IdType="pubmed">31823821</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotyla P.J., Kruszec-Zytniewska A., Owczarek A.J., Olszanecka-Glinianowicz M., Chudek J. Fibroblast Growth Factor 23 to Alpha-Klotho Index Correlates with Systemic Sclerosis Activity: A Proposal for Novel Disease Activity Marker. J. Clin. Med. 2018;7:558. doi: 10.3390/jcm7120558.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm7120558</ArticleId><ArticleId IdType="pmc">PMC6306722</ArticleId><ArticleId IdType="pubmed">30562918</ArticleId></ArticleIdList></Reference><Reference><Citation>Seriolo B., Molfetta L., Cutolo M. Seasonal variations in serum levels of 25-hydroxyvitamin D in patients with systemic sclerosis. Clin. Rheumatol. 2011;30:445&#x2013;446. doi: 10.1007/s10067-011-1684-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-011-1684-7</ArticleId><ArticleId IdType="pubmed">21234627</ArticleId></ArticleIdList></Reference><Reference><Citation>Vacca A., Cormier C., Piras M., Mathieu A., Kahan A., Allanore Y. Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis. J. Rheumatol. 2009;36:1924&#x2013;1929. doi: 10.3899/jrheum.081287.</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.081287</ArticleId><ArticleId IdType="pubmed">19648299</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmel N.N., Rotman-Pikielny P., Lavrov A., Levy Y. Vitamin D Antibodies in Systemic Sclerosis Patients: Findings and Clinical Correlations. Isr. Med. Assoc. J. 2015;17:80&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">26223082</ArticleId></ArticleIdList></Reference><Reference><Citation>An L., Sun M.H., Chen F., Li J.R. Vitamin D levels in systemic sclerosis patients: A meta-analysis. Drug Des. Devel. 2017;11:3119&#x2013;3125. doi: 10.2147/DDDT.S144860.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/DDDT.S144860</ArticleId><ArticleId IdType="pmc">PMC5667779</ArticleId><ArticleId IdType="pubmed">29138534</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaconu A.D., Ostafie I., Ceasovschih A., &#x218;orodoc V., Lionte C., Ancu&#x21b;a C., &#x218;orodoc L. Role of Vitamin D in Systemic Sclerosis: A Systematic Literature Review. J. Immunol. Res. 2021;2021:9782994. doi: 10.1155/2021/9782994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/9782994</ArticleId><ArticleId IdType="pmc">PMC8648450</ArticleId><ArticleId IdType="pubmed">34881335</ArticleId></ArticleIdList></Reference><Reference><Citation>Caimmi C., Bertoldo E., Pozza A., Caramaschi P., Orsolini G., Gatti D., Rossini M., Viapiana O. Vitamin D serum levels and the risk of digital ulcers in systemic sclerosis: A longitudinal study. Int. J. Rheum. Dis. 2019;22:1041&#x2013;1045. doi: 10.1111/1756-185X.13554.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.13554</ArticleId><ArticleId IdType="pubmed">30938067</ArticleId></ArticleIdList></Reference><Reference><Citation>Park E.K., Park J.H., Kweon S.M., Kim G.T., Lee S.G. Vitamin D deficiency is associated with digital ulcer but not with atherosclerosis or arterial stiffness in patients with systemic sclerosis: A pilot study. Clin. Rheumatol. 2017;36:1325&#x2013;1333. doi: 10.1007/s10067-017-3622-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-017-3622-9</ArticleId><ArticleId IdType="pubmed">28365806</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose N., Chiesa-Vottero A., Chatterjee S. Scleroderma renal crisis. Semin. Arthritis Rheum. 2015;44:687&#x2013;694. doi: 10.1016/j.semarthrit.2014.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2014.12.001</ArticleId><ArticleId IdType="pubmed">25613774</ArticleId></ArticleIdList></Reference><Reference><Citation>Rios-Fern&#xe1;ndez R., Callejas-Rubio J.L., Fern&#xe1;ndez-Rold&#xe1;n C., Sime&#xf3;n-Aznar C.P., Garc&#xed;a-Hern&#xe1;ndez F., Castillo-Garc&#xed;a M.J., Fonollosa Pla V., Barnosi Mar&#xed;n A.C., Gonz&#xe1;lez-Gay M., Ortego-Centeno N. Bone mass and vitamin D in patients with systemic sclerosis from two Spanish regions. Clin. Exp. Rheumatol. 2012;30:905&#x2013;911.</Citation><ArticleIdList><ArticleId IdType="pubmed">22935485</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibn Yacoub Y., Amine B., Laatiris A., Wafki F., Znat F., Hajjaj-Hassouni N. Bone density in Moroccan women with systemic scleroderma and its relationships with disease-related parameters and vitamin D status. Rheumatol. Int. 2012;32:3143&#x2013;3148. doi: 10.1007/s00296-011-2150-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-011-2150-1</ArticleId><ArticleId IdType="pubmed">21947376</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuggioli D., Colaci M., Cassone G., Fallahi P., Lumetti F., Spinella A., Campomori F., Manfredi A., Manzini C.U., Antonelli A., et al. Serum 25-OH vitamin D levels in systemic sclerosis: Analysis of 140 patients and review of the literature. Clin. Rheumatol. 2017;36:583&#x2013;590. doi: 10.1007/s10067-016-3535-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-016-3535-z</ArticleId><ArticleId IdType="pubmed">28070764</ArticleId></ArticleIdList></Reference><Reference><Citation>Azali P., Barbasso Helmers S., Kockum I., Olsson T., Alfredsson L., Charles P.J., Piehl Aulin K., Lundberg I.E. Low serum levels of vitamin D in idiopathic inflammatory myopathies. Ann. Rheum. Dis. 2013;72:512&#x2013;516. doi: 10.1136/annrheumdis-2012-201849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2012-201849</ArticleId><ArticleId IdType="pubmed">22993226</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox M., Sandler R.D., Matucci-Cerinic M., Hughes M. Bone health in idiopathic inflammatory myopathies. Autoimmun. Rev. 2021;20:102782. doi: 10.1016/j.autrev.2021.102782.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102782</ArticleId><ArticleId IdType="pubmed">33609795</ArticleId></ArticleIdList></Reference><Reference><Citation>Piantoni S., Andreoli L., Scarsi M., Zanola A., Dall&#x2019;Ara F., Pizzorni C., Cutolo M., Air&#xf2; P., Tincani A. Phenotype modifications of T-cells and their shift toward a Th2 response in patients with systemic lupus erythematosus supplemented with different monthly regimens of vitamin D. Lupus. 2015;24:490&#x2013;498. doi: 10.1177/0961203314559090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314559090</ArticleId><ArticleId IdType="pubmed">25801892</ArticleId></ArticleIdList></Reference><Reference><Citation>Andjelkovic Z., Vojinovic J., Pejnovic N., Popovic M., Dujic A., Mitrovic D., Pavlica L., Stefanovic D. Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin. Exp. Rheumatol. 1999;17:453&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pubmed">10464556</ArticleId></ArticleIdList></Reference><Reference><Citation>Gopinath K., Danda D. Supplementation of 1,25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: A randomised controlled trial. Int. J. Rheum. Dis. 2011;14:332&#x2013;339. doi: 10.1111/j.1756-185X.2011.01684.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1756-185X.2011.01684.x</ArticleId><ArticleId IdType="pubmed">22004229</ArticleId></ArticleIdList></Reference><Reference><Citation>Salesi M., Farajzadegan Z. Efficacy of vitamin D in patients with active rheumatoid arthritis receiving methotrexate therapy. Rheumatol. Int. 2012;32:2129&#x2013;2133. doi: 10.1007/s00296-011-1944-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-011-1944-5</ArticleId><ArticleId IdType="pubmed">21523344</ArticleId></ArticleIdList></Reference><Reference><Citation>Dehghan A., Rahimpour S., Soleymani-Salehabadi H., Owlia M.B. Role of vitamin D in flare ups of rheumatoid arthritis. Z Rheumatol. 2014;73:461&#x2013;464. doi: 10.1007/s00393-013-1297-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00393-013-1297-4</ArticleId><ArticleId IdType="pubmed">24352479</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen K.E., Bartels C.M., Gangnon R.E., Jones A.N., Gogineni J. An evaluation of high-dose vitamin D for rheumatoid arthritis. J. Clin. Rheumatol. 2014;20:112&#x2013;114. doi: 10.1097/RHU.0000000000000072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RHU.0000000000000072</ArticleId><ArticleId IdType="pmc">PMC4089514</ArticleId><ArticleId IdType="pubmed">24561419</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandrashekara S., Patted A. Role of vitamin D supplementation in improving disease activity in rheumatoid arthritis: An exploratory study. Int. J. Rheum. Dis. 2017;20:825&#x2013;831. doi: 10.1111/1756-185X.12770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.12770</ArticleId><ArticleId IdType="pubmed">26481198</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukherjee D., Lahiry S., Thakur S., Chakraborty D.S. Effect of 1,25 dihydroxy vitamin D3 supplementation on pain relief in early rheumatoid arthritis. J. Fam. Med. Prim. Care. 2019;8:517&#x2013;522. doi: 10.4103/jfmpc.jfmpc_446_18.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfmpc.jfmpc_446_18</ArticleId><ArticleId IdType="pmc">PMC6436291</ArticleId><ArticleId IdType="pubmed">30984665</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon O.C., Oh J.S., Park M.C., Kim Y.G. Effect of Vitamin D Supplementation on Bone Mineral Density in Rheumatoid Arthritis Patients With Osteoporosis. Front. Med. 2020;7:443. doi: 10.3389/fmed.2020.00443.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00443</ArticleId><ArticleId IdType="pmc">PMC7473387</ArticleId><ArticleId IdType="pubmed">32974365</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Franco M., Barchetta I., Iannuccelli C., Gerardi M.C., Frisenda S., Ceccarelli F., Valesini G., Cavallo M.G. Hypovitaminosis D in recent onset rheumatoid arthritis is predictive of reduced response to treatment and increased disease activity: A 12 month follow-up study. BMC Musculoskelet. Disord. 2015;16:53. doi: 10.1186/s12891-015-0505-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12891-015-0505-6</ArticleId><ArticleId IdType="pmc">PMC4373034</ArticleId><ArticleId IdType="pubmed">25887374</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan Y., Hao Y., Bu H., Wang H. The Effect of Vitamin D Supplementation on Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis. Front. Med. 2020;7:596007. doi: 10.3389/fmed.2020.596007.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.596007</ArticleId><ArticleId IdType="pmc">PMC7661491</ArticleId><ArticleId IdType="pubmed">33195358</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco A.S., Freitas T.Q., Bernardo W.M., Pereira R.M.R. Vitamin D supplementation and disease activity in patients with immune-mediated rheumatic diseases: A systematic review and meta-analysis. Medicine. 2017;96:e7024. doi: 10.1097/MD.0000000000007024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000007024</ArticleId><ArticleId IdType="pmc">PMC5466211</ArticleId><ArticleId IdType="pubmed">28591033</ArticleId></ArticleIdList></Reference><Reference><Citation>Singgih Wahono C., Diah Setyorini C., Kalim H., Nurdiana N., Handono K. Effect of Curcuma xanthorrhiza Supplementation on Systemic Lupus Erythematosus Patients with Hypovitamin D Which Were Given Vitamin D(3) towards Disease Activity (SLEDAI), IL-6, and TGF-&#x3b2;1 Serum. Int. J. Rheumatol. 2017;2017:7687053. doi: 10.1155/2017/7687053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7687053</ArticleId><ArticleId IdType="pmc">PMC5763117</ArticleId><ArticleId IdType="pubmed">29445400</ArticleId></ArticleIdList></Reference><Reference><Citation>Piemonti L., Monti P., Sironi M., Fraticelli P., Leone B.E., Dal Cin E., Allavena P., Di Carlo V. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J. Immunol. 2000;164:4443&#x2013;4451. doi: 10.4049/jimmunol.164.9.4443.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.164.9.4443</ArticleId><ArticleId IdType="pubmed">10779743</ArticleId></ArticleIdList></Reference><Reference><Citation>Weeres M.A., Robien K., Ahn Y.O., Neulen M.L., Bergerson R., Miller J.S., Verneris M.R. The effects of 1,25-dihydroxyvitamin D3 on in vitro human NK cell development from hematopoietic stem cells. J. Immunol. 2014;193:3456&#x2013;3462. doi: 10.4049/jimmunol.1400698.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1400698</ArticleId><ArticleId IdType="pmc">PMC4363084</ArticleId><ArticleId IdType="pubmed">25149465</ArticleId></ArticleIdList></Reference><Reference><Citation>Hewison M. Vitamin D and immune function: Autocrine, paracrine or endocrine? Scand. J. Clin. Lab. Invest. Suppl. 2012;243:92&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pubmed">22536769</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemire J.M., Archer D.C., Beck L., Spiegelberg H.L. Immunosuppressive actions of 1,25-dihydroxyvitamin D3: Preferential inhibition of Th1 functions. J. Nutr. 1995;125:1704s&#x2013;1708s.</Citation><ArticleIdList><ArticleId IdType="pubmed">7782931</ArticleId></ArticleIdList></Reference><Reference><Citation>Mocanu V., Oboroceanu T., Zugun-Eloae F. Current status in vitamin D and regulatory T cells&#x2014;Immunological implications. Rev. Med. Chir. Soc. Med. Nat. Iasi. 2013;117:965&#x2013;973.</Citation><ArticleIdList><ArticleId IdType="pubmed">24502077</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto E.A., J&#xf8;rgensen T.N. Relationships Between Vitamin D, Gut Microbiome, and Systemic Autoimmunity. Front. Immunol. 2019;10:3141. doi: 10.3389/fimmu.2019.03141.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.03141</ArticleId><ArticleId IdType="pmc">PMC6985452</ArticleId><ArticleId IdType="pubmed">32038645</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangin M., Sinha R., Fincher K. Inflammation and vitamin D: The infection connection. Inflamm. Res. 2014;63:803&#x2013;819. doi: 10.1007/s00011-014-0755-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00011-014-0755-z</ArticleId><ArticleId IdType="pmc">PMC4160567</ArticleId><ArticleId IdType="pubmed">25048990</ArticleId></ArticleIdList></Reference><Reference><Citation>Querfeld U. Vitamin D and inflammation. Pediatr. Nephrol. 2013;28:605&#x2013;610. doi: 10.1007/s00467-012-2377-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00467-012-2377-4</ArticleId><ArticleId IdType="pubmed">23239393</ArticleId></ArticleIdList></Reference><Reference><Citation>Charoenngam N., Shirvani A., Holick M.F. Vitamin D for skeletal and non-skeletal health: What we should know. J. Clin. Orthop. Trauma. 2019;10:1082&#x2013;1093. doi: 10.1016/j.jcot.2019.07.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcot.2019.07.004</ArticleId><ArticleId IdType="pmc">PMC6834997</ArticleId><ArticleId IdType="pubmed">31708633</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam M.Z., Bhuiyan N.H., Akhtaruzzaman M., Allardt C.L., Fogelholm M. Vitamin D deficiency in Bangladesh: A review of prevalence, causes and recommendations for mitigation. Asia Pac. J. Clin. Nutr. 2022;31:167&#x2013;180. doi: 10.6133/apjcn.202206_31(2).0002.</Citation><ArticleIdList><ArticleId IdType="doi">10.6133/apjcn.202206_31(2).0002</ArticleId><ArticleId IdType="pubmed">35766552</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlberg C. Vitamin D and Pigmented Skin. Nutrients. 2022;14:325. doi: 10.3390/nu14020325.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14020325</ArticleId><ArticleId IdType="pmc">PMC8781604</ArticleId><ArticleId IdType="pubmed">35057504</ArticleId></ArticleIdList></Reference><Reference><Citation>Alfredsson L., Armstrong B.K., Butterfield D.A., Chowdhury R., de Gruijl F.R., Feelisch M., Garland C.F., Hart P.H., Hoel D.G., Jacobsen R., et al. Insufficient Sun Exposure Has Become a Real Public Health Problem. Int. J. Env. Res. Public Health. 2020;17:5014. doi: 10.3390/ijerph17145014.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17145014</ArticleId><ArticleId IdType="pmc">PMC7400257</ArticleId><ArticleId IdType="pubmed">32668607</ArticleId></ArticleIdList></Reference><Reference><Citation>Luxwolda M.F., Kuipers R.S., Kema I.P., van der Veer E., Dijck-Brouwer D.A., Muskiet F.A. Vitamin D status indicators in indigenous populations in East Africa. Eur. J. Nutr. 2013;52:1115&#x2013;1125. doi: 10.1007/s00394-012-0421-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00394-012-0421-6</ArticleId><ArticleId IdType="pubmed">22878781</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlberg C. Nutrigenomics of Vitamin D. Nutrients. 2019;11:676. doi: 10.3390/nu11030676.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11030676</ArticleId><ArticleId IdType="pmc">PMC6470874</ArticleId><ArticleId IdType="pubmed">30901909</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>